Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal
Selma Ugurel

Showing results (341-350 of 411) with videos related to

Pageof 42
Sort By:
Cell Stem Cell|December 25, 2018
Identification of Embryonic Neural Plate Border Stem Cells and Their Generation by Direct Reprogramming from Adult Human Blood CellsMarc Christian Thier, Oliver Hommerding, Jasper Panten, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 17, 2023
S2k Guideline - Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - Update 2022Jürgen C Becker, Ambros J Beer, Viola K DeTemple, et al.
Cancer Cell|February 28, 2017
Endothelial Notch1 Activity Facilitates MetastasisElfriede Wieland, Juan Rodriguez-Vita, Sven S Liebler, et al.
Nature Communications|February 24, 2026
Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune responseCléa Dziagwa, Christian Seca, Coralie Capron, et al.
Oncotarget|October 23, 2018
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter studyJulia K Tietze, Andrea Forschner, Carmen Loquai, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockadeEleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
Lancet (London, England)|July 14, 2023
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trialJürgen C Becker, Selma Ugurel, Ulrike Leiter, et al.
The British Journal of Dermatology|December 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanomaJan-Malte Placke, Jenny Bottek, Renata Váraljai, et al.
Elife|September 5, 2018
Topography of cancer-associated immune cells in human solid tumorsJakob Nikolas Kather, Meggy Suarez-Carmona, Pornpimol Charoentong, et al.
Journal of Extracellular Vesicles|September 27, 2023
Inhibition of extracellular vesicle-derived miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytesEmma Rigg, Jiwei Wang, Zhiwei Xue, et al.
Pageof 42

Showing results (341-350 of 411) with videos related to

Sort By:
Pageof 42
Cell Stem Cell|December 25, 2018
Identification of Embryonic Neural Plate Border Stem Cells and Their Generation by Direct Reprogramming from Adult Human Blood CellsMarc Christian Thier, Oliver Hommerding, Jasper Panten, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 17, 2023
S2k Guideline - Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - Update 2022Jürgen C Becker, Ambros J Beer, Viola K DeTemple, et al.
Cancer Cell|February 28, 2017
Endothelial Notch1 Activity Facilitates MetastasisElfriede Wieland, Juan Rodriguez-Vita, Sven S Liebler, et al.
Nature Communications|February 24, 2026
Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune responseCléa Dziagwa, Christian Seca, Coralie Capron, et al.
Oncotarget|October 23, 2018
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter studyJulia K Tietze, Andrea Forschner, Carmen Loquai, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockadeEleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
Lancet (London, England)|July 14, 2023
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trialJürgen C Becker, Selma Ugurel, Ulrike Leiter, et al.
The British Journal of Dermatology|December 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanomaJan-Malte Placke, Jenny Bottek, Renata Váraljai, et al.
Elife|September 5, 2018
Topography of cancer-associated immune cells in human solid tumorsJakob Nikolas Kather, Meggy Suarez-Carmona, Pornpimol Charoentong, et al.
Journal of Extracellular Vesicles|September 27, 2023
Inhibition of extracellular vesicle-derived miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytesEmma Rigg, Jiwei Wang, Zhiwei Xue, et al.
Pageof 42